A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression

Lihua Y. Marmorstein, Alexander V. Kinev, Gordon K T Chan, Daniel A. Bochar, Hideo Beniya, Jonathan A. Epstein, Tim J. Yen, Ramin Shiekhattar

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Germline mutations of the human BRCA2 gene confer susceptibility to breast cancer. Although the function of the BRCA2 protein remains to be determined, murine cells homozygous for BRCA2 inactivation display chromosomal aberrations. We have isolated a 2 MDa BRCA2-containing complex and identified a structural DNA binding component, designated as BRCA2-Associated Factor 35 (BRAF35). BRAF35 contains a nonspecific DNA binding HMG domain and a kinesin-like coiled coil domain. Similar to BRCA2, BRAF35 mRNA expression levels in mouse embryos are highest in proliferating tissues with high mitotic index. Strikingly, nuclear staining revealed a close association of BRAF35/BRCA2 complex with condensed chromatin coincident with histone H3 phosphorylation. Importantly, antibody microinjection experiments suggest a role for BRCA2/BRAF35 complex in modulation of cell cycle progression.

Original languageEnglish (US)
Pages (from-to)247-257
Number of pages11
JournalCell
Volume104
Issue number2
DOIs
StatePublished - Jan 26 2001
Externally publishedYes

Fingerprint

Cell Cycle
BRCA2 Protein
Cells
BRCA2 Gene
Kinesin
Phosphorylation
Mitotic Index
Germ-Line Mutation
DNA
Microinjections
Aberrations
Chromosome Aberrations
Histones
Chromatin
Embryonic Structures
Genes
Modulation
Association reactions
Tissue
Staining and Labeling

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Marmorstein, L. Y., Kinev, A. V., Chan, G. K. T., Bochar, D. A., Beniya, H., Epstein, J. A., ... Shiekhattar, R. (2001). A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression. Cell, 104(2), 247-257. https://doi.org/10.1016/S0092-8674(01)00209-4

A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression. / Marmorstein, Lihua Y.; Kinev, Alexander V.; Chan, Gordon K T; Bochar, Daniel A.; Beniya, Hideo; Epstein, Jonathan A.; Yen, Tim J.; Shiekhattar, Ramin.

In: Cell, Vol. 104, No. 2, 26.01.2001, p. 247-257.

Research output: Contribution to journalArticle

Marmorstein, LY, Kinev, AV, Chan, GKT, Bochar, DA, Beniya, H, Epstein, JA, Yen, TJ & Shiekhattar, R 2001, 'A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression', Cell, vol. 104, no. 2, pp. 247-257. https://doi.org/10.1016/S0092-8674(01)00209-4
Marmorstein LY, Kinev AV, Chan GKT, Bochar DA, Beniya H, Epstein JA et al. A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression. Cell. 2001 Jan 26;104(2):247-257. https://doi.org/10.1016/S0092-8674(01)00209-4
Marmorstein, Lihua Y. ; Kinev, Alexander V. ; Chan, Gordon K T ; Bochar, Daniel A. ; Beniya, Hideo ; Epstein, Jonathan A. ; Yen, Tim J. ; Shiekhattar, Ramin. / A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression. In: Cell. 2001 ; Vol. 104, No. 2. pp. 247-257.
@article{0c2e496710504bff9ea64c0e6c0b71ed,
title = "A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression",
abstract = "Germline mutations of the human BRCA2 gene confer susceptibility to breast cancer. Although the function of the BRCA2 protein remains to be determined, murine cells homozygous for BRCA2 inactivation display chromosomal aberrations. We have isolated a 2 MDa BRCA2-containing complex and identified a structural DNA binding component, designated as BRCA2-Associated Factor 35 (BRAF35). BRAF35 contains a nonspecific DNA binding HMG domain and a kinesin-like coiled coil domain. Similar to BRCA2, BRAF35 mRNA expression levels in mouse embryos are highest in proliferating tissues with high mitotic index. Strikingly, nuclear staining revealed a close association of BRAF35/BRCA2 complex with condensed chromatin coincident with histone H3 phosphorylation. Importantly, antibody microinjection experiments suggest a role for BRCA2/BRAF35 complex in modulation of cell cycle progression.",
author = "Marmorstein, {Lihua Y.} and Kinev, {Alexander V.} and Chan, {Gordon K T} and Bochar, {Daniel A.} and Hideo Beniya and Epstein, {Jonathan A.} and Yen, {Tim J.} and Ramin Shiekhattar",
year = "2001",
month = "1",
day = "26",
doi = "10.1016/S0092-8674(01)00209-4",
language = "English (US)",
volume = "104",
pages = "247--257",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression

AU - Marmorstein, Lihua Y.

AU - Kinev, Alexander V.

AU - Chan, Gordon K T

AU - Bochar, Daniel A.

AU - Beniya, Hideo

AU - Epstein, Jonathan A.

AU - Yen, Tim J.

AU - Shiekhattar, Ramin

PY - 2001/1/26

Y1 - 2001/1/26

N2 - Germline mutations of the human BRCA2 gene confer susceptibility to breast cancer. Although the function of the BRCA2 protein remains to be determined, murine cells homozygous for BRCA2 inactivation display chromosomal aberrations. We have isolated a 2 MDa BRCA2-containing complex and identified a structural DNA binding component, designated as BRCA2-Associated Factor 35 (BRAF35). BRAF35 contains a nonspecific DNA binding HMG domain and a kinesin-like coiled coil domain. Similar to BRCA2, BRAF35 mRNA expression levels in mouse embryos are highest in proliferating tissues with high mitotic index. Strikingly, nuclear staining revealed a close association of BRAF35/BRCA2 complex with condensed chromatin coincident with histone H3 phosphorylation. Importantly, antibody microinjection experiments suggest a role for BRCA2/BRAF35 complex in modulation of cell cycle progression.

AB - Germline mutations of the human BRCA2 gene confer susceptibility to breast cancer. Although the function of the BRCA2 protein remains to be determined, murine cells homozygous for BRCA2 inactivation display chromosomal aberrations. We have isolated a 2 MDa BRCA2-containing complex and identified a structural DNA binding component, designated as BRCA2-Associated Factor 35 (BRAF35). BRAF35 contains a nonspecific DNA binding HMG domain and a kinesin-like coiled coil domain. Similar to BRCA2, BRAF35 mRNA expression levels in mouse embryos are highest in proliferating tissues with high mitotic index. Strikingly, nuclear staining revealed a close association of BRAF35/BRCA2 complex with condensed chromatin coincident with histone H3 phosphorylation. Importantly, antibody microinjection experiments suggest a role for BRCA2/BRAF35 complex in modulation of cell cycle progression.

UR - http://www.scopus.com/inward/record.url?scp=0035951405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035951405&partnerID=8YFLogxK

U2 - 10.1016/S0092-8674(01)00209-4

DO - 10.1016/S0092-8674(01)00209-4

M3 - Article

VL - 104

SP - 247

EP - 257

JO - Cell

JF - Cell

SN - 0092-8674

IS - 2

ER -